How can applying a ‘rare disease mindset’ accelerate and de-risk precision medicine trials?

Precision medicine studies in both rare and common diseases can benefit from taking a proactive rather than reactive approach to patient finding and engagement. In this 45 minute webinar, Patti Engel (President & CEO of Engage Health) and Patrick Short (Co-Founder & CEO of Sano Genetics) share lessons from a success story in running a proactive patient finding programme that combines: healthcare provider outreach, direct-to-patient outreach through patient organizations and social media, free next-generation DNA sequencing and a decentralized trial design